Who's Profiting From Your "Food Sensitivity"?

Picture this: you've been dealing with bloating, low energy, and unpredictable digestion for months. Nothing dramatic — just a persistent sense that your gut is staging a slow protest against your meals. You're frustrated, you want answers, and someone points you toward a food sensitivity panel. Three hundred dollars later, a report lands in your inbox. Forty-seven foods flagged. Bar graphs. Severity scores. A personalized elimination protocol. It looks clinical. It looks like science.

It isn't.

The food sensitivity testing industry has built a billion-dollar business on a simple trick: dress up normal immune function as a disease signal, sell the "diagnosis," then sell the follow-up. Your symptoms are real. The test is not.

Three Things We Keep Muddling

Let's start with the basics, because the terminology is doing a lot of heavy lifting for this industry.

Food allergy is a genuine IgE-mediated immune response. Your body produces immunoglobulin E antibodies against a specific protein — a peanut, a shrimp, a tree nut — and the reaction can range from hives to anaphylaxis. It's diagnosable through validated skin prick tests and serum IgE panels. The mechanism is understood. The stakes are serious. This is not the gray zone.

Food intolerance is real but mechanistically different. Lactose intolerance occurs when your gut doesn't produce enough lactase enzyme to break down milk sugar; the undigested lactose ferments in your colon and the results are unpleasant but not immunological. Celiac disease — a serious autoimmune reaction to gluten — has its own established diagnostic criteria involving intestinal biopsy and anti-tTG antibody testing. Neither of these requires a $300 panel to identify.

Food sensitivity is where the gray zone begins, and where the industry lives. The term has no agreed clinical definition. It describes a diffuse constellation of symptoms — bloating, fatigue, brain fog, skin flares — that people attribute to specific foods without a confirmable IgE mechanism. Some genuine physiological conditions fall under this umbrella: histamine intolerance, reactions to fermentable carbohydrates (FODMAPs), small intestinal bacterial overgrowth (SIBO). But the testing sold to identify food sensitivity is a separate matter entirely, and here the evidence is damning.

What the IgG Test Is Actually Measuring

The dominant product in the sensitivity testing market measures immunoglobulin G (IgG) antibodies — usually IgG4 — against a panel of foods. The pitch is emotionally coherent: your immune system has "reacted" to these foods, so they're your problem.

Basic immunology says otherwise. IgG4 antibodies indicate exposure — a normal, benign immune memory response that increases with dietary diversity. The American Academy of Allergy, Asthma & Immunology (AAAAI) has explicitly stated that IgG4 testing has no diagnostic validity for identifying food sensitivity or adverse food reactions. The Canadian Society of Allergy and Clinical Immunology agrees. The European Academy of Allergy and Clinical Immunology agrees. There is no credible dissenting position in mainstream immunology.

Here's the perverse logic built into the test: a person eating a genuinely varied, whole-food diet will have IgG4 responses to dozens of foods. That's not pathology — that's a functioning immune system doing its job. A person who has never eaten a papaya will not have papaya IgG4 antibodies, and their test will come back "clear." A person who eats eggs every morning for breakfast will have robust IgG4 responses to eggs, and their test will flag eggs as a problem.

The test didn't find your sensitivity. It mapped your grocery list. The company charged you $300 to confirm that you've been eating.

The Real Problem Hiding Behind the Fake Test

Here's what makes this more troubling than simple grift: the digestive distress driving people toward these tests is often genuine. Something is going wrong for a large and growing number of people. They're bloating after meals. Their energy is unpredictable. Their gut feels unreliable in ways it didn't used to. They want answers — and the medical system, which struggles with functional gastrointestinal disorders, often doesn't give them satisfying ones. The sensitivity testing industry fills that gap.

The more useful question is what changed in your food environment to produce these symptoms in the first place.

A 2025 analysis in The Lancet laid out the case plainly: ultra-processed foods have been systematically displacing whole-food diets worldwide, producing "gross nutrient imbalances, overeating driven by high energy density, and reduced intake of health-protective phytochemicals," with mounting evidence linking ultra-processed dietary patterns to cardiovascular disease, type 2 diabetes, obesity, cancer, and other chronic conditions (The Lancet, 2025). What the UPF literature has been slower to address — but is beginning to examine — is the gut-level disruption caused not just by what's absent from these foods, but by what's been added.

Emulsifiers like carboxymethylcellulose, carrageenan, and polysorbate 80 are standard ingredients in processed breads, ice creams, condiments, and packaged snacks. In animal models, several of these compounds disrupt the gut's mucosal barrier and alter microbial composition. Their effects on human gut permeability at the exposure levels common in modern diets remain inadequately studied — not because the research is impossible, but because no regulatory authority required it before these ingredients entered the food supply at scale. That's not a conspiracy. It's a regulatory gap that industry has had very little incentive to close.

The gut microbiome — the ecosystem that mediates digestion, synthesizes key metabolites, and modulates intestinal permeability — responds meaningfully to what you eat. A 2025 randomized crossover trial found that even modest fermented food interventions produced measurable changes in microbiome composition and circulating short-chain fatty acids over just four weeks, demonstrating how quickly and dynamically the gut adapts to dietary inputs (Schropp et al., 2025). If it responds that quickly to beneficial change, it responds to harmful change, too.

If your digestive symptoms emerged or worsened around the time your diet shifted toward more packaged, convenient, ultra-processed food — and for most people in the developed world, it did, gradually and almost invisibly — the culprit is more likely the aggregate disruption to your gut ecosystem than a sudden intolerance to almonds you've been eating for years.

What Actually Works

None of this means your symptoms deserve dismissal. They deserve real investigation.

The diagnostic gold standard for identifying genuine food reactions remains the double-blind, placebo-controlled food challenge — conducted under clinical supervision. For most people, a properly structured elimination diet, guided by a registered dietitian or gastroenterologist, can identify real triggers without pseudoscientific panels. The low-FODMAP elimination protocol, for instance, has genuine clinical evidence behind it for managing IBS symptoms; it's methodologically rigorous, has defined reintroduction phases, and is designed to produce actual data. That's what a validated dietary investigation looks like. (If you're dealing with persistent gastrointestinal symptoms, getting a proper clinical evaluation — not a wellness panel — is the right starting point.)

More broadly, reducing ultra-processed food is the intervention with the broadest and most consistent evidence base. The Lancet's 2025 synthesis is unambiguous about UPFs' role in degrading diet quality at a population level (The Lancet, 2025). Rebuilding a gut microbiome disrupted by years of emulsifiers, low fiber, and minimal whole foods takes time — but it responds to the effort.

The Business Model

The food sensitivity testing industry found a clever market. It converts the genuine suffering of people with poorly understood digestive symptoms into a diagnostic product that appears scientific. It operates in the white space between clinical medicine and the wellness economy — charging clinical-sounding prices for results the clinical establishment won't endorse, and conveniently producing findings that necessitate ongoing consultation, expensive specialty foods, and proprietary supplements.

The companies selling these tests know the AAAAI position. They know what IgG4 antibodies actually measure. They know the validation studies haven't been done. They built the business anyway, because enough people are hurting, and frustrated, and looking for a framework that makes the discomfort make sense.

Your gut symptoms deserve better than that.

Start with your food environment before you start eliminating 47 foods. And before you hand money to anyone selling you a diagnosis, ask which peer-reviewed body has validated the test they're using. The answer, for IgG-based panels, is none.

That question alone is worth the $300 you didn't spend.